Dear Editors
This letter is in response to the article ( We write to comment on the applicability of the method and provide our perception of the limitations of the analysis. We conclude that the findings fall short of sufficient and robust evidence in themselves, but are a valuable published source for a sample size calculation for a randomised controlled trial (RCT) which would be fully justified by their findings. (2) We have concerns about the applicability of the method in this instance. Matching studies open the opportunity to working on large existing data sets with completed follow up. For treatment comparisons they work best when, due to a difference in policy or availability of a treatment, some patients arbitrarily receive one, and some another, of two available treatments. The two treated groups can be considered as two circles of a Venn diagram. In the overlap are those who were treated in one way, but could have had the other. It is not as trustworthy evidence as blind randomisation but it is a route to exploratory analyses. In this instance all patients were carefully and expertly considered for one rather than the other treatment. Only recognised and documented features are on the available record. This was compiled in the full knowledge of whether the patients were selected for, and had a resection, or did not.(3) Randomisation avoids this shortcoming inherent in matching studies because it balances both known and unknown factors.
We also have concerns about the analysis. In full knowledge of the two treatment options, a decision was made to include or not include resection in the management in each of 1112 patients. Largely due to limitations on available data this number shrank to 458 who were 'potentially eligible for matching'. (Fig.1a&b) Figure 2 shows the votes of three surgeons on resectability among 56 patients. In an RCT risk of bias is diminished and it is tested for in a meta-analysis.(4) It may not have been in this study. Were the 'dedicated' surgeons blinded to outcomes and was the whole analysis independently scrutinised? There was disagreement on resectability in 20 and lack of concordance about the resection strategy in a further 19.
Whether one expects the more rigorous use of only 17 patients where a treatment decision was unanimous, or accepts the authors selected 36 patients on 2/3 majority votes, it is still a small and highly selected sample. These would be inadequate numbers for an RCT.
The researchers provide methods and hard-won results but there is a compelling argument for independent readers to be allowed to interpret and draw their own conclusions.(5) Our conclusion is that an RCT appears to be mandatory for this burdensome treatment. In 27 of the patients at least one or more of the surgeons would now use staged procedures including portal vein embolization or combination with radio-frequency ablation. RFA has been shown in a published RCT to confer no survival advantage: "The study shows that local tumor ablation by RFA in combination with systemic therapy results in an excellent survival, which however was also achieved in the control arm." 
